QUARTI TREVANO FOSCA ANNA LUISA

Cuspidi, C., Facchetti, R., Quarti-Trevano, F., Tadic, M., Vanoli, J., Mancia, G., et al. (2026). Targeting the Association between Interarm Blood Pressure Difference and Subclinical Organ Damage: Findings from the PAMELA Study. AMERICAN JOURNAL OF HYPERTENSION, 39(4 (April 2026)), 570-577 [10.1093/ajh/hpaf207]. Detail

Massabò, D., Quarti-Trevano, F., Seravalle, G., Facchetti, R., Dell'Oro, R., Tsioufis, K., et al. (2025). FAILURE OF ANTIHYPERTENSIVE TREATMENT TO RESTORE NORMAL SYMPATHETIC ACTIVITY. JOURNAL OF HYPERTENSION, 43(S1), 214-214 [10.1097/01.hjh.0001117400.59486.c3]. Detail

Cuspidi, C., Facchetti, R., Quarti-Trevano, F., Dell'Oro, R., Faggiano, A., Mancia, G., et al. (2025). New onset left atrial dilatation in the general population: A quarter-century follow-up. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 137, 105-111 [10.1016/j.ejim.2025.05.001]. Detail

Russo, E., Viazzi, F., Pontremoli, R., Angeli, F., Barbagallo, C., Berardino, B., et al. (2025). Predictive value of TG/HDL-C and GFR-adjusted uric acid levels on cardiovascular mortality: the URRAH study. LIPIDS IN HEALTH AND DISEASE, 24(1) [10.1186/s12944-025-02440-w]. Detail

Quarti-Trevano, F., Seravalle, G., Facchetti, R., Tsioufis, K., Dimitriadis, K., Manta, E., et al. (2025). Failure of Antihypertensive Treatment to Restore Normal Sympathetic Activity. HYPERTENSION, 82(6), 1024-1034 [10.1161/HYPERTENSIONAHA.124.24429]. Detail